NCT01068483 Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT01065662 AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies Status COMPLETED Phase PHASE1
NCT01065441 Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01059643 A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01048814 Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases Status COMPLETED Phase N/A
NCT01047891 Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01041235 Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies Status COMPLETED Phase PHASE1
NCT01040312 An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors Status COMPLETED Phase N/A
NCT01035658 Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT01034033 Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples Status RECRUITING Phase N/A
NCT01033292 A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01033123 A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01031381 Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer Status COMPLETED Phase PHASE2
NCT01017809 Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer Status WITHDRAWN Phase NA
NCT01016054 A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer Status TERMINATED Phase PHASE1
NCT01012336 Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin Status COMPLETED Phase PHASE2